Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-01-05
1989-12-05
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
048853054
ABSTRACT:
Novel nasal pharmaceutical composition adapted to be absorbed systemically through the nasal mucus and comprising as active agent a calcium antagonist selected from optionally substituted, 1,4-dihydropyridines bearing in the 4 position a monocyclic ring, together with a nontoxic pharmaceutically aceptable nasal carrier therefor.
REFERENCES:
patent: 4497821 (1985-02-01), Wehinger et al.
patent: 4525341 (1985-06-01), Deihl
patent: 4537898 (1985-08-01), Hoff et al.
patent: 4607041 (1986-08-01), Baxter et al.
patent: 4622332 (1986-11-01), Wehinger et al.
patent: 4686217 (1987-08-01), Baxter et al.
patent: 4722931 (1988-02-01), Casanova et al.
Dittert, Sprowls' American Pharmacy, 7th Ed. (1974) p. 416.
Letters to the Editor, J. Pharm. Pharmac., 1972, 24; 917; Loev et al.
European Journal of Pharmacology, 54 (1979) 289-293 Jolly et al.
Van De Donk et al; First European Congress of Biopharmaceutics and Pharmacokinetics; pp. 406-414.
Sucken et al; Pharmazeutische Technologie, Deutschland (1978), pp. 722-729; English Translation enclosed.
Acezat-Mispelter Francoise
Kiechel Jean-Rene
Plas Danielle
Robinson Allen J.
Yamanouchi Pharmaceutical Co. Ltd.
LandOfFree
Nasal compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nasal compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nasal compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034689